Division for Cancer Pharmacology – Young Investigators Symposium
Tuesday April 09, 2019
4:00 pm
-
6:00 pm
Eastern Time (ET)
Room W206 B
DCP
Chair :
Mary-Ann Bjornsti
Univ of Alabama- Birmingham
Jack Yalowich
Ohio State University
This session will feature oral presentations by young scientists that were selected from the submitted abstracts.
Speakers
Joseph Flores-Toro
- University of Florida
CCR2 Inhibition Reduces Tumor-Associated Myeloid-Derived Suppressor Cells and Unmasks an α-PD-1 Effect to Slow Tumor Progression in Checkpoint Inhibitor Resistant Gliomas
Sreedhar Reddy Suthe
- Texas Tech University Health Sciences Center
RON Receptor-Targeted Antibody-Drug Conjugate Therapy Ablates Cancer Stem Cells and Induces Longterm Tumor Regressions in Preclinical Models of Triple-Negative Breast Cancer (TNBC)
Xuan Yang
- Emory University
Discovery and Interrogation of New Mechanism to Control MYC Oncogene by Mitogen-Activated Protein Kinase Kinase 3
Shreoshi Pal Choudhuri
- UT Southwestern Medical Center
Pancreatic Ductal Adenocarcinoma Tumor Suppressors Rgs8-16
Hilary Nicholson
- Dana-Farber Cancer Institute / Harvard Medical School
Loss of CDK4/6 Activity Is Synthetic Lethal with VHL Inactivation in Clear Cell Renal Cell Carcinoma
Reiya Hayden
- University of Kentucky
Mithramycin Analogues Disrupt ETS Transcription Tfactor DNA Binding
Sharon Garrott
- University of Virginia
The Mechanism of Inhibition of the Undrugged Oncogenic Phosphatase PTP4A3 by a Novel Small Molecule JMS-053